JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation

Gilyoung Lee; Huijeong Ahn; Jang Hyuk Yun; Jeongho Park; Eunsong Lee; Seikwan Oh; Geun Shik Lee

doi:10.1038/s41598-022-27129-3

JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation

Gilyoung Lee, Huijeong Ahn, Jang Hyuk Yun, Jeongho Park, Eunsong Lee, Seikwan Oh, Geun Shik Lee

Department of Molecular Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Dysregulation of inflammasome activation induces chronic and excess inflammation resulting in several disorders, such as metabolic disorders and cancers. Thus, screening for its regulator derived from natural materials has been conducted progressively. JC2-11 (JC) was designed to enhance the antioxidant activity based on a chalcone, which is abundant in edible plants and a precursor of flavonoids. This study examined the effects of JC on inflammasome activation in human and murine macrophages. JC inhibited the secretion of interleukin (IL)-1β and lactate dehydrogenases, and the cleavage of caspase-1 and gasdermin D in response to the tested activators (i.e., NLRP3, NLRC4, AIM2, and non-canonical inflammasome triggers). In addition, JC attenuated IL-1β secretion from lipopolysaccharide (LPS)-injected mice, an inflammasome-mediating disease model. Mechanistically, JC blocked the expression of the inflammasome components during the priming step of the inflammasome, and interrupted the production of mitochondrial reactive oxygen species. In addition, JC inhibited the activity of caspase-1. In conclusion, JC may be a candidate pan-inflammasome inhibitor.

Original language	English
Article number	22484
Journal	Scientific Reports
Volume	12
Issue number	1
DOIs	https://doi.org/10.1038/s41598-022-27129-3
State	Published - Dec 2022

Bibliographical note

Funding Information:
We would like to acknowledge all authors for their highly valuable contributions to this special issue. Also, we would like to express our gratitude to the reviewers whose constructive comments helped to improve the quality of the articles. The authors would like to thank “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil” (CAPES, Finance Code 001) and “Conselho Nacional de Desenvolvimento Científico e Tecnológico–Brasil” (CNPq) for grants and fellowships.

Funding Information:
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2018R1A2B2004097 and NRF-2018R1D1A1B07048337).

Publisher Copyright:
© 2022, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41598-022-27129-3

Cite this

@article{3bc7f7017a75465b8c0b78efccdec283,

title = "JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation",

abstract = "Dysregulation of inflammasome activation induces chronic and excess inflammation resulting in several disorders, such as metabolic disorders and cancers. Thus, screening for its regulator derived from natural materials has been conducted progressively. JC2-11 (JC) was designed to enhance the antioxidant activity based on a chalcone, which is abundant in edible plants and a precursor of flavonoids. This study examined the effects of JC on inflammasome activation in human and murine macrophages. JC inhibited the secretion of interleukin (IL)-1β and lactate dehydrogenases, and the cleavage of caspase-1 and gasdermin D in response to the tested activators (i.e., NLRP3, NLRC4, AIM2, and non-canonical inflammasome triggers). In addition, JC attenuated IL-1β secretion from lipopolysaccharide (LPS)-injected mice, an inflammasome-mediating disease model. Mechanistically, JC blocked the expression of the inflammasome components during the priming step of the inflammasome, and interrupted the production of mitochondrial reactive oxygen species. In addition, JC inhibited the activity of caspase-1. In conclusion, JC may be a candidate pan-inflammasome inhibitor.",

author = "Gilyoung Lee and Huijeong Ahn and Yun, {Jang Hyuk} and Jeongho Park and Eunsong Lee and Seikwan Oh and Lee, {Geun Shik}",

note = "Funding Information: We would like to acknowledge all authors for their highly valuable contributions to this special issue. Also, we would like to express our gratitude to the reviewers whose constructive comments helped to improve the quality of the articles. The authors would like to thank “Coordena{\c c}{\~a}o de Aperfei{\c c}oamento de Pessoal de N{\'i}vel Superior–Brasil” (CAPES, Finance Code 001) and “Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico–Brasil” (CNPq) for grants and fellowships. Funding Information: This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2018R1A2B2004097 and NRF-2018R1D1A1B07048337). Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1038/s41598-022-27129-3",

language = "English",

volume = "12",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation

AU - Lee, Gilyoung

AU - Ahn, Huijeong

AU - Yun, Jang Hyuk

AU - Park, Jeongho

AU - Lee, Eunsong

AU - Oh, Seikwan

AU - Lee, Geun Shik

N1 - Funding Information: We would like to acknowledge all authors for their highly valuable contributions to this special issue. Also, we would like to express our gratitude to the reviewers whose constructive comments helped to improve the quality of the articles. The authors would like to thank “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil” (CAPES, Finance Code 001) and “Conselho Nacional de Desenvolvimento Científico e Tecnológico–Brasil” (CNPq) for grants and fellowships. Funding Information: This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2018R1A2B2004097 and NRF-2018R1D1A1B07048337). Publisher Copyright: © 2022, The Author(s).

PY - 2022/12

Y1 - 2022/12

N2 - Dysregulation of inflammasome activation induces chronic and excess inflammation resulting in several disorders, such as metabolic disorders and cancers. Thus, screening for its regulator derived from natural materials has been conducted progressively. JC2-11 (JC) was designed to enhance the antioxidant activity based on a chalcone, which is abundant in edible plants and a precursor of flavonoids. This study examined the effects of JC on inflammasome activation in human and murine macrophages. JC inhibited the secretion of interleukin (IL)-1β and lactate dehydrogenases, and the cleavage of caspase-1 and gasdermin D in response to the tested activators (i.e., NLRP3, NLRC4, AIM2, and non-canonical inflammasome triggers). In addition, JC attenuated IL-1β secretion from lipopolysaccharide (LPS)-injected mice, an inflammasome-mediating disease model. Mechanistically, JC blocked the expression of the inflammasome components during the priming step of the inflammasome, and interrupted the production of mitochondrial reactive oxygen species. In addition, JC inhibited the activity of caspase-1. In conclusion, JC may be a candidate pan-inflammasome inhibitor.

AB - Dysregulation of inflammasome activation induces chronic and excess inflammation resulting in several disorders, such as metabolic disorders and cancers. Thus, screening for its regulator derived from natural materials has been conducted progressively. JC2-11 (JC) was designed to enhance the antioxidant activity based on a chalcone, which is abundant in edible plants and a precursor of flavonoids. This study examined the effects of JC on inflammasome activation in human and murine macrophages. JC inhibited the secretion of interleukin (IL)-1β and lactate dehydrogenases, and the cleavage of caspase-1 and gasdermin D in response to the tested activators (i.e., NLRP3, NLRC4, AIM2, and non-canonical inflammasome triggers). In addition, JC attenuated IL-1β secretion from lipopolysaccharide (LPS)-injected mice, an inflammasome-mediating disease model. Mechanistically, JC blocked the expression of the inflammasome components during the priming step of the inflammasome, and interrupted the production of mitochondrial reactive oxygen species. In addition, JC inhibited the activity of caspase-1. In conclusion, JC may be a candidate pan-inflammasome inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=85145031169&partnerID=8YFLogxK

U2 - 10.1038/s41598-022-27129-3

DO - 10.1038/s41598-022-27129-3

M3 - Article

C2 - 36577816

AN - SCOPUS:85145031169

SN - 2045-2322

VL - 12

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 22484

ER -

JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Cite this